Carpenter 科技

最新新闻

• 评级变动
  KeyBanc Maintains Carpenter Technology(CRS.US) With Buy Rating, Cuts Target Price to $608
  \u5e02\u573a\u8d44\u8baf · 2026/8/4
• TD Cowen Maintains Carpenter Technology(CRS.US) With Buy Rating, Cuts Target Price to $500
  \u5e02\u573a\u8d44\u8baf · 2026/10/9
• 公司公告
  ULTIMATE HLDGS GROUP INC | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-CRS Consulting, LLC(1.00%),Thomas DeNunzio(0.33%), etc.
  SEC · 2023/4/27
• 公司公告
  BLUBUZZARD INC | SC 13D: Statement of acquisition of beneficial ownership by individuals-CRS Consulting, LLC(72.25%),Thomas DeNunzio(24.08%), etc.
  SEC · 2024/6/13
• KeyBanc Maintains Carpenter Technology(CRS.US) With Buy Rating, Cuts Target Price to $465
  \u5e02\u573a\u8d44\u8baf · 2026/10/8
• 公司公告
  AnPac Bio-Medical Science | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-CRS Holdings Inc.(0.06%),Chris Chang Yu(0.06%)
  SEC · 2022/10/13
• 公司公告
  ULTIMATE HLDGS GROUP INC | SC 13D: Statement of acquisition of beneficial ownership by individuals-CRS Consulting, LLC(81.75%),Thomas DeNunzio(27.25%), etc.
  SEC · 2022/12/1
• 评级变动
  Deutsche Bank Maintains Carpenter Technology(CRS.US) With Buy Rating, Raises Target Price to $689
  \u5e02\u573a\u8d44\u8baf · 2026/7/31
• 评级变动
  TD Cowen Maintains Carpenter Technology(CRS.US) With Buy Rating, Raises Target Price to $650
  \u5e02\u573a\u8d44\u8baf · 2026/7/13
• 评级变动
  J.P. Morgan Maintains Carpenter Technology(CRS.US) With Buy Rating, Maintains Target Price $700
  \u5e02\u573a\u8d44\u8baf · 2026/8/5
• 评级变动
  J.P. Morgan Maintains Carpenter Technology(CRS.US) With Buy Rating, Raises Target Price to $705
  \u5e02\u573a\u8d44\u8baf · 2026/7/14
• Wells Fargo Maintains Carpenter Technology(CRS.US) With Hold Rating, Raises Target Price to $430
  \u5e02\u573a\u8d44\u8baf · 2026/9/30
• 评级变动
  BTIG Maintains Carpenter Technology(CRS.US) With Buy Rating, Raises Target Price to $620
  \u5e02\u573a\u8d44\u8baf · 2026/7/31
• SIG Maintains Carpenter Technology(CRS.US) With Buy Rating, Maintains Target Price $600
  \u5e02\u573a\u8d44\u8baf · 2026/10/7
• 公司公告
  AnPac Bio-Medical Science | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-CRS Holdings Inc.(0.06%),Chris Chang Yu(0.06%)
  SEC · 2022/10/13
• 评级变动
  SIG Maintains Carpenter Technology(CRS.US) With Buy Rating, Raises Target Price to $680
  \u5e02\u573a\u8d44\u8baf · 2026/7/9
• 评级变动
  J.P. Morgan Remains a Buy on Carpenter Technology (CRS)
  TipRanks · 2026/7/13
• 评级变动
  J.P. Morgan Maintains Carpenter Technology(CRS.US) With Buy Rating, Raises Target Price to $700
  \u5e02\u573a\u8d44\u8baf · 2026/7/31
• Adicet Bio Announces Safety And Efficacy Data From Phase 1 Study Evaluating Prulacabtagene Leucel In Patients With Systemic Lupus Erythematosus With Or Without Lupus Nephritis; Prula-Cel Generally Well Tolerated With No CRS Greater Than Grade 2 And No...
  Benzinga · 2026/9/28
• 评级变动
  SIG Maintains Carpenter Technology(CRS.US) With Buy Rating, Cuts Target Price to $600
  \u5e02\u573a\u8d44\u8baf · 2026/7/31
• Carpenter Technology(CRS.US) Officer Sells US$52.88 Million in Common Stock
  \u5e02\u573a\u8d44\u8baf · 2026/8/28
• 评级变动
  TD Cowen Maintains Carpenter Technology(CRS.US) With Buy Rating, Maintains Target Price $470
  \u5e02\u573a\u8d44\u8baf · 2026/5/22
• 评级变动
  KeyBanc Maintains Carpenter Technology(CRS.US) With Buy Rating, Raises Target Price to $644
  \u5e02\u573a\u8d44\u8baf · 2026/6/30

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。